Company profile
ABBOTT LABORATORIES
NYSE:ABTBiotechnology: Pharmaceutical Preparations
Drug pipeline (85)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| ABT-072 | phase1 | — | 8 | no active trials |
| ABT-102 | phase1 | — | 1 | no active trials |
| ABT-384 | phase1 | — | 3 | no active trials |
| ABT-436 | phase1 | — | 3 | completed, terminated |
| ABT-510 | phase2 | — | 2 | completed, terminated |
Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.
Clinical trials (320)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01176201 | phase1 | completed | 2010-07-01 | 2010-10-01 | Abbott Products | 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man |
| NCT01674712 | phase3 | completed | 2012-06-01 | 2013-10-01 | Abbott | A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease |
| NCT00195793 | phase3 | completed | 2004-08-01 | — | Abbott | A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin |
| NCT00743470 | phase1 | terminated | 2008-08-01 | 2008-10-01 | Abbott | A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects |
| NCT00513370 | phase3 | completed | 2007-09-01 | 2008-09-01 | Abbott | A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis |
FDA applications (117)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| ANDA 061802 | ANDA | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | ||||
Loading… | ||||||
| ANDA 062305 | ANDA | ROSS LABORATORIES DIV ABBOTT LABORATORIES INC | ||||
Loading… | ||||||
| ANDA 062306 | ANDA | ROSS LABORATORIES DIV ABBOTT LABORATORIES INC | ||||
Loading… | ||||||
| ANDA 062413 | ANDA | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | ||||
Loading… | ||||||
| ANDA 062547 | ANDA | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV | ||||
Loading… | ||||||